174 related articles for article (PubMed ID: 9453404)
21. Predicting the effect of intravenous calcitriol on parathyroid gland activity using double-phase technetium Tc 99m-sestamibi scintigraphy.
Torregrosa JV; Fuster D; Ybarra J; Ortín J; Moreno A; Valveny N
Am J Kidney Dis; 2004 Sep; 44(3):476-80. PubMed ID: 15332220
[TBL] [Abstract][Full Text] [Related]
22. Prospective comparison of dual-phase technetium-99m-sestamibi scintigraphy and high resolution ultrasonography in the evaluation of abnormal parathyroid glands.
Light VL; McHenry CR; Jarjoura D; Sodee DB; Miron SD
Am Surg; 1996 Jul; 62(7):562-7; discussion 567-8. PubMed ID: 8651552
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of technetium-99m-MIBI scan and intraoperative methylene blue staining for the localization of abnormal parathyroid glands.
Takei H; Iino Y; Endo K; Horiguchi J; Maemura M; Koibuchi Y; Horii Y; Yokoe T; Ishida T; Oyama T; Morishita Y
Surg Today; 1999; 29(4):307-12. PubMed ID: 10211559
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of ⁹⁹mTc-sestamibi SPECT/CT for minimally invasive parathyroidectomy: comparative study with ⁹⁹mTc-sestamibi scintigraphy, SPECT, US and CT.
Kim YI; Jung YH; Hwang KT; Lee HY
Ann Nucl Med; 2012 Dec; 26(10):804-10. PubMed ID: 22875576
[TBL] [Abstract][Full Text] [Related]
25. Persistent secondary hyperparathyroidism caused by parathyromatosis and supernumerary parathyroid glands in a patient on haemodialysis.
Yang J; Zhang J; Liu NH; Liu H; Dong MJ
BMC Nephrol; 2020 Jul; 21(1):257. PubMed ID: 32631272
[TBL] [Abstract][Full Text] [Related]
26. Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression.
Royal RE; Delpassand ES; Shapiro SE; Fritsche HA; Vassilopoulou-Sellin R; Sherman SI; Gagel RF; Evans DB; Lee JE
Surgery; 2002 Dec; 132(6):968-74; discussion 974-5. PubMed ID: 12490843
[TBL] [Abstract][Full Text] [Related]
27. Can localization studies be used to direct focused parathyroid operations?
Arici C; Cheah WK; Ituarte PH; Morita E; Lynch TC; Siperstein AE; Duh QY; Clark OH
Surgery; 2001 Jun; 129(6):720-9. PubMed ID: 11391371
[TBL] [Abstract][Full Text] [Related]
28. Limited sensitivity of parathyroid imaging with (99m)Tc-sestamibi/(123)I subtraction in an endemic goiter area.
Rink T; Schroth HJ; Holle LH; Garth H
J Nucl Med; 2002 Sep; 43(9):1175-80. PubMed ID: 12215555
[TBL] [Abstract][Full Text] [Related]
29. Sestamibi scintigraphy, topography, and histopathology of parathyroid glands in secondary hyperparathyroidism.
Lomonte C; Buonvino N; Selvaggiolo M; Dassira M; Grasso G; Vernaglione L; Basile C
Am J Kidney Dis; 2006 Oct; 48(4):638-44. PubMed ID: 16997060
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I.
Caveny SA; Klingensmith WC; Martin WE; Sage-El A; McIntyre RC; Raeburn C; Wolfe P
J Nucl Med Technol; 2012 Jun; 40(2):104-10. PubMed ID: 22566587
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging (MRI) and technetium-99m-methoxyisonitrile (MIBI) scintigraphy to evaluate the abnormal parathyroid gland and PEIT efficacy for secondary hyperparathyroidism.
Wada A; Sugihara M; Sugimura K; Kuroda H
Radiat Med; 1999; 17(4):275-82. PubMed ID: 10510900
[TBL] [Abstract][Full Text] [Related]
32. 11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis.
Rubello D; Fanti S; Nanni C; Farsad M; Castellucci P; Boschi S; Franchi R; Mariani G; Fig LM; Gross MD
Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):453-9. PubMed ID: 16435115
[TBL] [Abstract][Full Text] [Related]
33. Impaired Tc-99m MIBI uptake in the thyroid and parathyroid glands during early phase imaging in hemodialysis patients.
Kiratli PO; Ceylan E; Naldöken S; Beylergil V
Rev Esp Med Nucl; 2004; 23(5):347-51. PubMed ID: 15450141
[TBL] [Abstract][Full Text] [Related]
34. Comparison of histological findings and parathyroid scintigraphy in hemodialysis patients with secondary hyperparathyroid glands.
Nishida H; Ishibashi M; Hiromatsu Y; Kaida H; Baba K; Miyake I; Ikedo H; Kato S; Fukami K; Iida S; Okuda S
Endocr J; 2005 Apr; 52(2):223-8. PubMed ID: 15863952
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid imaging: the importance of pinhole collimation with both single- and dual-tracer acquisition.
Klingensmith WC; Koo PJ; Summerlin A; Fehrenbach BW; Karki R; Shulman BC; Raeburn CD; McIntyre RC
J Nucl Med Technol; 2013 Jun; 41(2):99-104. PubMed ID: 23539762
[TBL] [Abstract][Full Text] [Related]
36. [Preoperative scintigraphic localization of hyperfunctioning parathyroid glands].
Zimmermann-Belsing T; Mollerup CL; Rabøl A; Schaadt BK; Christensen LH; Blichert-Toft M; Feldt-Rasmussen UF
Ugeskr Laeger; 1996 Mar; 158(13):1827-31. PubMed ID: 8650758
[TBL] [Abstract][Full Text] [Related]
37. P-gp and MRP1 expression in parathyroid tumors related to histology, weight and (99m)Tc-sestamibi imaging results.
Jorna FH; Hollema H; Hendrikse HN; Bart J; Brouwers AH; Plukker JT
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):406-12. PubMed ID: 19235131
[TBL] [Abstract][Full Text] [Related]
38. Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas.
Bleier BS; LiVolsi VA; Chalian AA; Gimotty PA; Botbyl JD; Weber RS
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):779-82. PubMed ID: 16847189
[TBL] [Abstract][Full Text] [Related]
39. Tc-99m sestamibi parathyroid gland scintigraphy: added value of Tc-99m pertechnetate thyroid imaging for increasing interpretation confidence and avoiding additional testing.
Powell DK; Nwoke F; Goldfarb RC; Ongseng F
Clin Imaging; 2013; 37(3):475-9. PubMed ID: 23102932
[TBL] [Abstract][Full Text] [Related]
40. An algorithm to maximize use of minimally invasive parathyroidectomy.
Quiros RM; Alioto J; Wilhelm SM; Ali A; Prinz RA
Arch Surg; 2004 May; 139(5):501-6; discussion 506-7. PubMed ID: 15136350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
